No. 9 / 2025Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate ...

HELLERUP, Denmark, April 11, 2025 /PRNewswire/ -- Following exercise of 365,096 original RSUs granted in the 2022 Long Term Incentive Program and the 2023 Retention Program, the Board of Directors ...

For the financial year 2025, the total aggregated value of grants under the Long-term incentive programs, including RSUs and PSUs, cannot exceed 400% of the fixed annual salary for the CEO and 250 ...

Zealand Pharma (ZLDPF) announces the implementation of long-term incentive programs for 2025 for Zealand Pharma’s Board of Directors, Corporate ...

Following exercise of 365,096 original RSUs granted in the 2022 Long Term Incentive Program and the 2023 Retention Program, the Board of Directors has decided to grant certain employees ('Participants ...